Aside from in vitro research, we then investigated the correlations between CEBPD, hsa-miR-429 and VEGFA expression and their associations with microvascular density and clinical aggressiveness in UBUC and UTUC cohorts comprised of cancer tissue samples from 295 and 340 patients, respectively. This evidence concerns the gene VEGFA and renal pelvis/ureter urothelial carcinoma.